Biomet Inc., a global leader in the manufacture of orthopedic and biotechnology products, and OrthoSensor, a leader in intelligent orthopedics, are pleased to announce a co-promotion partnership with Biomet’s Vanguard Complete Knee System and OrthoSensor’s VERASENSE.

“Biomet is thrilled with its relationship with OrthoSensor and is excited to add this sensor technology to our Vanguard Knee platform. We believe that the impact this will have on soft tissue balancing will be dramatic.”

OrthoSensor VERASENSE is a trial bearing designed for use with the Vanguard Complete Knee System, which is embedded with sensors and microelectronics to provide surgeons with real-time knee kinetic data. The sensors wirelessly transmit information to a graphic display, allowing surgeons to quantify soft-tissue loads throughout the range of motion. This enables the surgeon to make informed adjustments to the soft tissues and implant placement in order to allow for overall knee balancing. Research has shown that soft tissue balance may aid in the reduction of pain, polyethylene wear, and aseptic loosening while improving patients’ proprioception.

Jay Pierce, CEO of OrthoSensor, stated, “Combining Biomet’s Vanguard Knee System with VERASENSE takes knee replacement surgery to a new level of precision by providing surgeons with actionable, intraoperative data to quantify and verify that they balance a knee implant properly during total knee replacement surgery. We are extremely pleased to partner with Biomet and expand access to OrthoSensor’s technology for surgeons using the Vanguard system.”

Todd O. Davis, Biomet general manager and vice president of Global Knees, commented, “Biomet is thrilled with its relationship with OrthoSensor and is excited to add this sensor technology to our Vanguard Knee platform. We believe that the impact this will have on soft tissue balancing will be dramatic.”

Source: Biomet Inc., Inside INdiana Business